Австралия - английский - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - donepezil hydrochloride -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - donepezil hydrochloride -

Соединенные Штаты - английский - NLM (National Library of Medicine)

physicians total care, inc. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 10 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer’s type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer’s disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. enter section text here pregnancy category c : there are no adequate or well-controlled studies in pregnant women. donepezil hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of donepezil to pregnant rats and rabbits during the period of organogenesis did not produce any teratogenic effects at doses up to 16 mg/kg/day (approximately 16 times the maximum recommended human dose [mrhd] of 10 mg/day on a mg/m 2 basis) and 10 mg/kg/day (approximately 20 times the mrhd on a mg/m2 basis), respectively. oral administration of donepezil (1, 3, 10 mg/kg/day) to rats during late gestatio

Австралия - английский - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - donepezil hydrochloride monohydrate, quantity: 5.22 mg (equivalent: donepezil hydrochloride, qty 5 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; lactose monohydrate; hyprolose; titanium dioxide; hypromellose; macrogol 400 - treatment of mild, moderate and severe alzheimer's disease.

Соединенные Штаты - английский - NLM (National Library of Medicine)

carilion materials management - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 10 mg - donepezil hydrochloride tablets, usp are indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride tablets are contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. pregnancy category c there are no adequate or well-controlled studies in pregnant women. donepezil hydrochloride tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of donepezil to pregnant rats and rabbits during the period of organogenesis did not produce any teratogenic effects at doses up to 16 mg/kg/day (approximately 16 times the maximum recommended human dose [mrhd] of 10 mg/day on a mg/m2 basis) and 10 mg/kg/day (approximately 20 times the mrhd on a mg/m2 basis), respectively. oral administration of donepezil (1, 3, 10 mg/kg/day) to rats during late gestation and throughout l

Соединенные Штаты - английский - NLM (National Library of Medicine)

remedyrepack inc. - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride is indicated for the treatment of dementia of the alzheimer’s type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochlorideis contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil hydrochloride in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major birth

Канада - английский - Health Canada

vanc pharmaceuticals inc - donepezil hydrochloride - tablet - 5mg - donepezil hydrochloride 5mg - parasympathomemetic (cholinergic) agents

Канада - английский - Health Canada

vanc pharmaceuticals inc - donepezil hydrochloride - tablet - 10mg - donepezil hydrochloride 10mg - parasympathomemetic (cholinergic) agents

Канада - английский - Health Canada

jamp pharma corporation - donepezil hydrochloride - tablet - 5mg - donepezil hydrochloride 5mg - parasympathomemetic (cholinergic) agents

Канада - английский - Health Canada

jamp pharma corporation - donepezil hydrochloride - tablet - 10mg - donepezil hydrochloride 10mg - parasympathomemetic (cholinergic) agents